Insider Trading & Ownership of Catherine M. Burzik

Summary
The estimated net worth of Catherine M. Burzik is at least $6,717,040 dollars as of 30 Jan 2025. Catherine M. Burzik is the Director of BECTON DICKINSON & CO and owns shares of BECTON DICKINSON & CO (BDX) stock worth about $3.42M. Catherine M. Burzik is the Director of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $1.69M. Catherine M. Burzik is the Director of Orthofix Medical Inc. and owns shares of Orthofix Medical Inc. (OFIX) stock worth about $1.61M.
Signature
Donna Kalazdy, by power of attorney for Catherine M. Burzik
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Catherine M. Burzik and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Catherine M. Burzik has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $6,717,040.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: BECTON DICKINSON & CO ($3,423,360).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Catherine M. Burzik

HAE Forms 3/4/5

HAEMONETICS CORP

Relationship
Director
Holdings value
$1,688,493
Past year net change
Change %
Report period
05 Aug 2022

Insider Transactions Reported by Catherine M. Burzik:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .